FDA Approves Cetuximab for Metastatic Head and Neck Cancer | Oral Cancer News
Links shared publicly online about this topic.
- 0total visits
FDA Approves Cetuximab for Metastatic Head and Neck Cancer | Oral Cancer News
FDA Approves Cetuximab for Metastatic Head and Neck Cancer | Oral Cancer News
View full resource at oralcancernews.org
Tags: Chemotherapy, Diet and Nutrition, Drug, FDA, Erbitux, Bristol-Myers Squibb, News
Most Recently Shared on November 8, 2011 at 8:33 pm By:
OCF News Update: FDA Approves Cetuximab for Metastatic Head and Neck Cancer http://t.co/Pfo0egHz
FDA Approves Cetuximab for Late-Stage Head and Neck Cancer | Oral Cancer News
oralcancernews.org — “FDA Approves Cetuximab for Late-Stage Head and Neck Cancer | Oral Cancer News” View full resource at oralcancernews.org
Most Recently Shared on November 9, 2011 at 1:05 pm By:
US FDA approval for expanded use of Erbitux | Oral Cancer News
oralcancernews.org — “US FDA approval for expanded use of Erbitux | Oral Cancer News” View full resource at oralcancernews.org
Most Recently Shared on November 9, 2011 at 8:24 am By:
Advertisement
